|
Feb 14
|
Moderna Q4 Earnings and Revenues Beat, COVID Vaccine Sales Decline
|
|
Feb 14
|
AI and robotics, Moderna earnings, GameStop: Market Minute
|
|
Feb 14
|
Moderna Posts Wider-Than-Expected Q4 Loss, 2025 Sales Outlook Disappoints
|
|
Feb 14
|
Moderna's Quarterly Loss Widens, Cost Cuts Planned as COVID-19 Vaccine Demand Falls
|
|
Feb 14
|
Moderna's Q4 loss: Can the pharma giant get to profitability?
|
|
Feb 14
|
Moderna Posts Wider-Than-Expected Quarterly Loss; Revenue Declines Annually
|
|
Feb 14
|
Retail sales, reciprocal tariffs, Coinbase earnings: 3 Things
|
|
Feb 14
|
Moderna Stock Falls on Earnings Report. The Results Reaffirm a Grim Picture for Vaccine Maker.
|
|
Feb 14
|
Moderna Struggles With Declining Q4 COVID Vaccine Sales, Stock Slides
|
|
Feb 14
|
Moderna (MRNA) Reports Q4 Loss, Tops Revenue Estimates
|
|
Feb 14
|
Moderna stock up at the opening bell despite mixed 2024 earnings
|
|
Feb 14
|
Moderna: Q4 Earnings Snapshot
|
|
Jan 3
|
Moderna (MRNA) Rises But Trails Market: What Investors Should Know
|
|
Jan 2
|
Why Moderna Inc. (MRNA) Is Skyrocketing
|
|
Dec 31
|
S&P 500 Gains and Losses Today: Index Slips as Stocks Close Out Strong Year
|
|
Dec 31
|
Top Stock Movers Now: Moderna, Verisign, Dave, and More
|
|
Dec 31
|
This Biotech Is One of the S&P 500’s Worst Performers. It Looks Too Cheap.
|
|
Oct 1
|
Moderna doses first subject in Phase III trial of mRNA norovirus vaccine in US
|
|
Oct 1
|
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
|
|
Sep 30
|
Moderna (MRNA) Rises Higher Than Market: Key Facts
|